CD8A and pancreatic ductal adenocarcinoma: Studies demonstrated that DPP inhibition altered the CXCR3 axis and enhanced NK and CD8+ T-cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma (41).